Guidant Defibrillator Deal Expanded To $240M
Boston Scientific Corp. upped its settlement in the product liability multidistrict litigation over faulty Guidant Corp. defibrillators on Monday, agreeing to pay $240 million to settle claims from more than 8,500...To view the full article, register now.
Already a subscriber? Click here to view full article